T. Evans Wyckoff Lecture in Neuroscience
The T. Evans Wyckoff Lecture in Neuroscience at Virginia Mason was established in 2000 by Ann Pigott Wyckoff in honor of her late husband, Theodore Evans Wyckoff. The lectureship is the Neuroscience Institute’s premiere annual event, featuring internationally-renowned physicians and researchers in the field of neuroscience. Lectures are free and open to the medical community.
Stanley H. Appel, MD is Co-director of Houston Methodist Neurological Institute, chair of the Stanley H. Appel Department of Neurology, and the Peggy and Gary Edwards Distinguished Chair in ALS at Houston Methodist Hospital. He is also Professor of Neurology at Weill Cornell Medical College.
An internationally renowned researcher and neurologist, Dr. Appel is dedicated to the treatment of patients with ALS and is one of the nation's foremost experts on the disease. He has published 16 books and over 400 peer-reviewed articles, and has been awarded a number of prestigious awards for his work, both nationally and internationally.
Save the Date
Stanley Appel, MD
19th Annual T. Evans Wyckoff Lecturer
Friday, October 25, 2019, 7:30 a.m.
Volney Richmond Auditorium
1201 Terry Ave, Seattle, WA 98101
The T. Evans Wyckoff Lecture in Neuroscience Endowed Fund annually provides funding to bring to the Virginia Mason campus a prominent leader in neuroscience to present his or her work in the field to the medical community.
Theodore Evans Wyckoff was a lumber entrepreneur and former director of the Washington State Department of Commerce and Economic Development. He had an unquenchable thirst for learning and adventure. When diagnosed with ALS, Mr. Wyckoff took it upon himself to research and learn about his diagnosis with the same enthusiasm as his other intellectual pursuits. He always asked hard questions, sought truth and wisdom, welcomed contradictory opinions, and took pride in healthy debate. Today, his family continues his values in education and new knowledge with this lectureship.
Past presenters include:
2018 — Christopher P. Ames, MD, University of California, San Francisco
"Frailty, Predictive Analytics and Cost in the New Era of Patient Specific Medicine"
2017 — Tahseen Mozaffar, MD, University of California, Irvine, School of Medicine
“Of Mice and Men: Lessons Learned from the Muscle Atrophy Inhibition Trials in Neurological Disorders”
2016 — Amit Bar-Or, MD, McGill University
"Evolving Insights and Therapies for Multiple Sclerosis"
2015 — John M. Ravits, MD, UC San Diego School of Medicine
“What Is C9orf72 Amyotrophic Lateral Sclerosis and Why Is It Rocking the Field of Neurodegeneration?”
2014 — Richard A. Deyo, MD, MPH, Oregon Health and Science University
“Overuse in the Treatment of Low Back Pain: Time to Back Off?”
2013 — Stanley A. Herring, MD, University of Washington Medicine Health System
“Youth Sports Concussion Legislation: The Zackery Lystedt Story”
2012 — Teepu Siddique, MD, Feinberg School of Medicine, Northwestern University
“ALS: A Ubiquilinopathy”
2011 — Kathleen M. Foley, MD, Memorial Sloan-Kettering Cancer Center
“Advancing Pain and Palliative Care Nationally: Challenges and Opportunities”
2010 — Stephen Salloway, MD, M.S., Brown University
“Clinical Best Practices in Dementia Care: Now and in the Future”
2009 — Andrew A. Eisen, MD, University of British Columbia
“Controversies in ALS – Some Personal Perspectives”
2008 — Louis R. Caplan, MD, Harvard Medical School
2007 — Bruce L. Miller, MD, University of California, San Francisco
“New Molecular and Clinical Links Between Frontotemporal Dementia and Amyotrophic Lateral Sclerosis”
2006 — Stephen L. Hauser, MD, University of California, San Francisco
“Genetics of Multiple Sclerosis”
2005 — Lewis P. Rowland, MD, The Neurological Institute of New York at Columbia University Medical Center “What’s New in ALS Research? A Personal List of the Top Ten Advances”
2003 — Jerome B. Posner, MD, Memorial Sloan-Kettering Cancer Center
2002 — James M. Schumacher, MD, University of Miami Center for Movement Disorders
“Parkinson’s Disease and New Developments in Parkinson’s Disease Surgery”
2001 — Robert H. Brown, Jr., MD, D.Phil, Harvard Medical School
“Neurogenetics and Molecular Biology in Neurodegenerative Diseases”
2000 — Robert G. Miller, MD, California Pacific Medical Center
“New Hope in the Battle Against ALS”